Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
(-) JNJ Press releases
(-) Other news
Partner news

Period

2021
2020
2019

Jul
Sep
Nov

Locations & regions

APAC
East North America
(-) EMEA
West North America

Focus area

Pharmaceuticals

Clear filters

News

JNJ Press releases

19 November 2021

Johnson & Johnson Innovation becomes a leading partner of Sitem Startup Club

Read full story

JNJ Press releases

21 September 2021

LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS

Read full story

JNJ Press releases

21 September 2021

New report reveals strength of the UK’s thriving genomics sector

Read full story

JNJ Press releases

20 September 2021

MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES

Read full story

25 November 2020

Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures

Read full story

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story

Sidebar

Currently trending

Currently trending

Locus Biosciences Announces $35 Million Financing
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Bioasis Enters Into Research Collaboration With Janssen
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biocom conference charts prospects for life sciences industry amid stock market volatility
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Trending

Trending

A JLABS Collaboration: DC4U

A JLABS Collaboration: Neurocast

Johnson & Johnson Innovation: Our Partnership Story